Brito Ana Maria G, Dos Santos Derivaldo, Rodrigues Sheyla A, Brito Renan G, Xavier-Filho Lauro
Institute of Technology and Research, Department of Biomedicine, Tiradentes University, Aracaju-SE, Brazil.
Pharmacogn Rev. 2013 Jan;7(13):34-41. doi: 10.4103/0973-7847.112840.
The search for more effective new drugs to treat Leishmaniasis is undoubtedly relevant. Our objective in this study was to investigate research publications addressing plants with anti-Leishmaniasis activity. An integrative review of the literature from 2000 to 2011 was carried out in the databases such as Latin-American and Caribbean Health Sciences (LILACS), Scientific Electronic Library Online (SciELO), and Medical Literature Analysis and Retrieval System Online (MEDLINE). In the initial search, 150 articles were found, with 25 based in LILACS, 68 in SciELO, and 46 in MEDLINE. From these data, after reading the abstracts that were available online, we excluded 12 from LILACS, 39 from SciELO, and 28 from MEDLINE for presenting article duplications. This left 61 articles to be read; however, only 18 of them answered the research questions and determined the final sample of this review. The results showed that research involving the search for new drugs against Leishmaniasis should be intensified, especially for the amastigote form, and studies with in vivo tests could become a great strategy for successfully finding new treatments for Leishmaniasis. It is believed that it is extremely important and urgent to conduct more trials in search of new effective drugs against Leishmaniasis that possess minimal adverse effects and that are easily accessible to the public.
寻找更有效的治疗利什曼病的新药无疑具有重要意义。本研究的目的是调查有关具有抗利什曼病活性植物的研究出版物。在拉丁美洲和加勒比卫生科学数据库(LILACS)、科学电子图书馆在线数据库(SciELO)和医学文献分析与联机检索系统(MEDLINE)等数据库中,对2000年至2011年的文献进行了综合综述。在初步检索中,共找到150篇文章,其中25篇来自LILACS,68篇来自SciELO,46篇来自MEDLINE。根据这些数据,在阅读了在线提供的摘要后,我们排除了LILACS中的12篇、SciELO中的39篇和MEDLINE中的28篇重复文章。剩下61篇文章需要阅读;然而,其中只有18篇回答了研究问题并确定了本综述的最终样本。结果表明,针对利什曼病寻找新药的研究应加强,尤其是针对无鞭毛体形式的研究,而体内试验研究可能成为成功找到利什曼病新治疗方法的重要策略。人们认为,开展更多试验以寻找对利什曼病有效的新药极其重要和紧迫,这些新药应具有最小的副作用且公众易于获得。